Back

Predictors for adverse outcomes in ICD/CRT-D patients: insights from a single-center study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular implantable electronic device in patients with heart failure Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sofia Andraz

Algarve University Hospital Center, Faro (Portugal)

6 More presentations in this session

Presentation thumbnail
Non-conventional versus conventional pacing in cardiac amyloidosis: impact on clinical, electrical, and functional outcomes
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
What makes hearts race in cardiac implantable electronic device patients?
Doctor M. Rodrigues Simoes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Left bundle branch area pacing versus biventricular pacing upgrade in pacemaker-induced cardiomyopathy: a comparison of short-term outcomes
Doctor B. Dobai (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
Doctor A. Diaz Exposito (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Left Bundle Branch Area Defibrillation (LBBAD) using ICD lead in the LBBAP position
Doctor A. Briski (Duesseldorf, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular implantable electronic device in patients with heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study
thumbnail
Congress Presentation
Right ventricular systolic pressure is an independent risk factor of all-cause death and inappropriate therapies in patients with implanted CRT-D
thumbnail
Congress Presentation
Cardiac resynchronization therapy - beyond ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources